Number of Shares
16.12 Mil
Current Holdings Value*
$329.90 Mil
% of Portfolio
15.08%
Total Estimate Gain
$154.33 Mil
% of Total Estimate Gain
73.75%

Frazier Life Sciences Management, L.P.'s NewAmsterdam Pharma Co NV Holding Summary

As of 2025-03-31, Frazier Life Sciences Management, L.P. held 16.12 Mil shares of NewAmsterdam Pharma Co NV(NAMS), totaling $329.90 Mil. This investment constitutes 15.08% of their stock portfolio, and Frazier Life Sciences Management, L.P. now holds 14.36% of the outstanding NewAmsterdam Pharma Co NV(NAMS) stock.

The initial trade took place in 2022Q4. And since then Frazier Life Sciences Management, L.P. has made 7 purchases of NAMS, at an average price of $12.98, for a total of 16.12 Mil shares. Based on historical transaction data and NAMS's current price of $22.56, Frazier Life Sciences Management, L.P.'s estimated gain on his NAMS holdings is $154.33 Mil, reflecting a 73.75% gain to date.

Frazier Life Sciences Management, L.P. NAMS ($22.56) Holding Chart

Frazier Life Sciences Management, L.P. NAMS ($22.56) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1